These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Use of evidence-based management for acute coronary syndrome. Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502 [TBL] [Abstract][Full Text] [Related]
26. Can enoxaparin safely replace unfractionated heparin during coronary intervention in acute coronary syndromes? Wolak A; Ayzenberg Y; Cafri C; Gilutz H; Ilia R; Zahger D Int J Cardiol; 2004 Aug; 96(2):151-5. PubMed ID: 15262028 [TBL] [Abstract][Full Text] [Related]
27. A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes. Califf RM; Petersen JL; Hasselblad V; Mahaffey KW; Ferguson JJ Am Heart J; 2005 Apr; 149(4 Suppl):S91-9. PubMed ID: 16124953 [TBL] [Abstract][Full Text] [Related]
28. Enoxaparin in non-ST segment elevation acute coronary syndromes: duration of therapy is essential to benefit. Steg PG; Juliard JM Eur Heart J; 2004 Oct; 25(19):1667-9. PubMed ID: 15451141 [No Abstract] [Full Text] [Related]
29. Reversal of protein-losing enteropathy with heparin therapy in an adult patient with congenital heart disease. Tsuzuki T; Okada H; Takenaka R; Kawahara Y; Kato J; Okazaki H; Kawamoto H; Shiratori Y Digestion; 2006; 74(3-4):206-7. PubMed ID: 17341854 [No Abstract] [Full Text] [Related]
30. Role of heparin in the antithrombotic treatment of valvulopathies. Hanania G J Heart Valve Dis; 2004 May; 13(3):339-43. PubMed ID: 15222278 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of cold abscesses by in situ and intravenous injections of heparin]. ALBERT-WEIL J Prensa Med Argent; 1954 Nov; 41(45):3221-7. PubMed ID: 13236996 [No Abstract] [Full Text] [Related]
32. [Use of heparin in the treatment of coronary diseases; heparin in coronary diseases except infarct]. CAMERON-CURRY V Minerva Med; 1957 Jan; 48(6):183-7. PubMed ID: 13418464 [No Abstract] [Full Text] [Related]
33. [Experience with discontinuous heparin in coronary insufficiency]. SAN-CRISTOBAL D; SEPULVEDA G Rev Med Chil; 1953 Nov; 81(11):662-5. PubMed ID: 13156131 [No Abstract] [Full Text] [Related]
34. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease. Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576 [TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis. Borentain M; Montalescot G; Bouzamondo A; Choussat R; Hulot JS; Lechat P Catheter Cardiovasc Interv; 2005 Jun; 65(2):212-21. PubMed ID: 15900551 [TBL] [Abstract][Full Text] [Related]
36. [Subcutaneous heparin treatment in cardiosclerosis]. VON AHN B Sven Lakartidn; 1957 Dec; 54(52):3945-55. PubMed ID: 13519397 [No Abstract] [Full Text] [Related]